Phase
Condition
Fungal Infections
Vaginitis
Yeast Infections
Treatment
Pimafucin® (natamycin) 100 mg vaginal suppositories
Lactulose 300 mg vaginal suppositories
Natamycin + Lactulose 100 mg + 300 mg vaginal suppositories
Clinical Study ID
Ages 18-60 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
two or more of the following signs and symptoms of vulvovaginal candidiasis: whiteor yellowish-white curd-like, thick or creamy vaginal discharge; vulvar itching,burning and pain; anogenital itching and burning; discomfort in the vulva; itching,burning, painful urination (dysuria);
yeast cells in the vaginal swab specimen;
vaginal pH ≤ 4.5.
Exclusion
Exclusion Criteria:
- a clinical and laboratory diagnosis of bacterial vaginosis; vulvovaginitis caused byspecific pathogens such as Trichomonas vaginalis, Chlamydia trachomatis, Neisseriagonorrhoeae; chronic inflammatory, atrophic, or oncologic diseases of the femalegenital tract; previous surgery on external or internal genitalia within 6 months;childbirth and abortion within 6 months.
Study Design
Connect with a study center
Department of Reproductive Medicine and Surgery at the A.I. Evdokimov Moscow State Medical and Dental University
Moscow,
Russian FederationSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.